Clinical Trial Update: Boceprevir in End Stage Renal Disease (ESRD) [NA]

View source ↗

Summary

A Columbia University-sponsored clinical trial evaluating boceprevir for hepatitis C in patients with end-stage renal disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hepatitis C

Drugs mentioned

• Victrelis (boceprevir) (boceprevir)

Snippet

Sponsor: Columbia University | Conditions: Hepatitis C Infection, End Stage Renal Disease | NA | Status: WITHDRAWN